Aelin Therapeutics
Provider of a biotherapeutics platform technology called pept-ins that are intended to harnesses.
Launch date
Employees
Market cap
-
Enterprise valuation
€108—162m (Dealroom.co estimates Dec 2017.)
Company register number 0685.688.842
Leuven Flemish Brabant (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | - | <1m | <1m | <1m |
| % growth | - | - | 33 % | (98 %) |
| Profit | (4.8m) | (5.6m) | (7.3m) | <1m |
| % profit margin | - | (53838 %) | (52444 %) | 175912 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
€27.0m | Series A | ||
N/A | Spinout | ||
| Total Funding | €27.0m | ||